首页> Clinical infectious diseases : an official publication of the Infectious Diseases Society of America> Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study.

Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study.

导出 OA

翻译打印收藏纠错

第一作者： Matthew A,Spinelli

第一单位： Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.

作者： Matthew A,Spinelli ^[1] ; Michael J,Peluso ^[1] ; Kara L,Lynch ^[2] ; Cassandra,Yun ^[2] ; David V,Glidden ^[3] ; Timothy J,Henrich ^[1] ; Steven G,Deeks ^[1] ; Monica,Gandhi ^[1]

作者单位： Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco, California, USA. ^[1] Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA. ^[2] Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. ^[3]

关键词 COVID-19 HIV SARS-CoV-2 immune response vaccination